HOME ZACKS RESEARCH FUNDS PORTFOLIO BROKER RESEARCH MARKETS SCREENING EDUCATION SERVICES
Zacks Rank    Equity Research    Premium Home    My Account    Help    


Top Stocks Set to Outperform
Over the Next 1 to 3 Months.

Click for your free picks >>

Quote:
Login Free Membership
Search:

 
Analyst Blog  

Consolidation Squeezing HDIX

November 28, 2007 | Comments: 0
Recommended this article (1)
HDIX | JNJ | MDT
Print    Share

A Hold recommendation has recently been issued to medical products company Home Diagnostics, Inc. (HDIX - Snapshot Report) by Zacks senior healthcare industry analyst Gregory Aurand, CFA.  Here's what his latest update stated:

"Home Diagnostics, Inc. is a developer, manufacturer and marketer of blood glucose monitoring systems and disposable supplies. The company has two large concentrated customers, and we believe the company's strategy of providing low-cost blood glucose systems under its co-branding plan could affect its future pricing capabilities.

"Customer consolidation could also reduce the growth outlook. As well, we expect increased competition from Johnson & Johnson (JNJ - Analyst Report) and Medtronic (MDT - Analyst Report), and the MMA competitive bidding program will also likely pressure the top- and bottom-line in 2008. Our target is $9.00 and our rating is Hold. Although the company reported third quarter EPS that exceeded expectations, higher gross margin offset weaker revenues.

"Management also reduced forward guidance for the remainder of 2007, partly due to channel consolidation and distributor changes. Given the risk factors, and low growth outlook, we believe the company should trade at a discount to comparables. At a 20% discount to the group average 1.4x 2008 P/E/G, we believe HDIX is fairly valued at $9.00. Our rating on the stock is Hold."

Read the full analyst report on HDIX

Read the full analyst report on JNJ

Read the full analyst report on MDT
 


Email

Print

Share

RSS

Rate Pos

Rate Neg

Comment
Read/Post Comments (0) | Recommended this article (1)
 Posting Comment...
There was a problem posting this this comment. Please try back later.
[CLICK TO CLOSE X]
Comments (Limit 1000 Characters - Used: 0)
Display Name: Email Address:  
 Loading Comments...
Be the first to comment on this article!
Best Stocks. Best Insight. Join Now...it's FREE!
Over 550,000 investors look forward to the timely insights in our email newsletter; Zacks Profit from the Pros. In each daily issue you will find:
  • Free  Four Zacks #1 Rank "Strong Buy" Stocks
  • Free  Timely Market Commentary
  • Free  Wealth Management Tips
  • Free  Profitable Strategy Screens
  • Free  Bull and Bear Stocks of the Day
Zacks FREE Registration

More Zacks Resources

Market Summary Nov 26, 2009 08:08 am ET
DJIA 10464.4  30.69 0.29%
NASD 2176.05  6.87 0.32%
S&P 500 1110.63  4.98 0.45%
Sponsored Links